buspirone has been researched along with Behavior Disorders in 17 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Buspirone is an anxiolytic drug and is a partial agonist for the serotonin 5-HT(1A) receptors as well as possessing low affinity and is an antagonist for the dopamine D(2) autoreceptors, with some evidence of a weak affinity to 5-HT(2) receptors." | 2.48 | Buspirone: what is it all about? ( Loane, C; Politis, M, 2012) |
| "Lifetime psychiatric illness is also common in women with PMDD, and although mood disorders predominate, past histories of anxiety disorders are also common, further suggesting an association between PMDD and anxiety disorders." | 2.40 | Anxiety symptoms and anxiety disorders: how are they related to premenstrual disorders? ( Yonkers, KA, 1997) |
| "Although essentially limited to alcohol abusers, clinical studies seem to support the preclinical findings that a number of 5-HT reuptake inhibitors decrease interest in and intake of alcohol in mild-moderate ethanol-dependent individuals." | 2.38 | Opportunities for treatment of psychoactive substance use disorders with serotonergic medications. ( Higgins, GA; Romach, MK; Sellers, EM; Tomkins, DM; Toneatto, T, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.76) | 18.7374 |
| 1990's | 12 (70.59) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Langleben, DD | 1 |
| Loane, C | 1 |
| Politis, M | 1 |
| Cugurra, F | 1 |
| Fernandez, F | 1 |
| Levy, JK | 1 |
| Schneider, LS | 1 |
| Zayas, EM | 1 |
| Grossberg, GT | 1 |
| Yonkers, KA | 1 |
| Spigset, O | 1 |
| Adielsson, G | 1 |
| Holzer, JC | 1 |
| Argyropoulos, SV | 1 |
| Nutt, DJ | 1 |
| Fawcett, J | 1 |
| Kravitz, HM | 1 |
| McGuire, M | 1 |
| Easton, M | 1 |
| Ross, J | 1 |
| Pisani, V | 1 |
| Fogg, LF | 1 |
| Clark, D | 1 |
| Whitney, M | 1 |
| Kravitz, G | 1 |
| Javaid, J | 1 |
| Teas, G | 1 |
| Glitz, DA | 1 |
| Pohl, R | 1 |
| Sellers, EM | 1 |
| Higgins, GA | 1 |
| Tomkins, DM | 1 |
| Romach, MK | 1 |
| Toneatto, T | 1 |
| Robinson, DS | 1 |
| Shrotriya, RC | 1 |
| Alms, DR | 1 |
| Messina, M | 1 |
| Andary, J | 1 |
| Rickels, K | 1 |
8 reviews available for buspirone and Behavior Disorders
| Article | Year |
|---|---|
Buspirone: what is it all about?
Topics: Animals; Buspirone; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Humans; Mental Disor | 2012 |
[Consequences of prolonged use of psychoactive drugs. Substitute natural treatment and individual psychotherapy].
Topics: Anti-Anxiety Agents; Benzodiazepines; Buspirone; Cannabis; Humans; Mental Disorders; Plants, Medicin | 1994 |
Psychopharmacology in HIV spectrum disorders.
Topics: Acquired Immunodeficiency Syndrome; AIDS Dementia Complex; Anti-Anxiety Agents; Antipsychotic Agents | 1994 |
Overview of generalized anxiety disorder in the elderly.
Topics: Adolescent; Adult; Age Factors; Age of Onset; Aged; Anti-Anxiety Agents; Antipsychotic Agents; Anxie | 1996 |
Anxiety symptoms and anxiety disorders: how are they related to premenstrual disorders?
Topics: 1-Naphthylamine; Adult; Age of Onset; Anxiety; Anxiety Disorders; Buspirone; Carbon Dioxide; Comorbi | 1997 |
The use of benzodiazepines in anxiety and other disorders.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Benzodiazepines; Buspirone; Carbolines; Humans; | 1999 |
5-HT1A partial agonists. What is their future?
Topics: Animals; Antidepressive Agents; Buspirone; Humans; Mental Disorders; Receptors, Serotonin; Serotonin | 1991 |
Opportunities for treatment of psychoactive substance use disorders with serotonergic medications.
Topics: Alcoholism; Animals; Buspirone; Comorbidity; Humans; Mental Disorders; Psychotropic Drugs; Rats; Rec | 1991 |
2 trials available for buspirone and Behavior Disorders
| Article | Year |
|---|---|
Pharmacological treatments for alcoholism: revisiting lithium and considering buspirone.
Topics: Adult; Alcoholism; Anti-Anxiety Agents; Antimanic Agents; Buspirone; Double-Blind Method; Humans; Li | 2000 |
Treatment of panic disorder: nonbenzodiazepine anxiolytics, including buspirone.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Buspirone; Fear; Female; Humans; Male; Mental Disorders | 1989 |
7 other studies available for buspirone and Behavior Disorders
| Article | Year |
|---|---|
Focus on addiction: Buspirone for cocaine relapse and monitoring controlled substances prescribed to dually diagnosed patients.
Topics: Analgesics, Opioid; Anti-Anxiety Agents; Buspirone; Cocaine-Related Disorders; Controlled Substances | 2014 |
Buspirone:seven-year update.
Topics: Buspirone; Geriatrics; Humans; Mental Disorders; Primary Health Care; Smoking Cessation | 1994 |
Treating the agitated Alzheimer patient.
Topics: Adrenergic beta-Antagonists; Aged; Aggression; Alzheimer Disease; Antipsychotic Agents; Buspirone; C | 1996 |
Drugs for psychiatric disorders.
Topics: Aged; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety; Benzodi | 1997 |
Combined serotonin syndrome and hyponatraemia caused by a citalopram-buspirone interaction.
Topics: Aged; Buspirone; Citalopram; Depressive Disorder; Drug Interactions; Female; Humans; Hyponatremia; M | 1997 |
Buspirone and brain injury.
Topics: Anti-Anxiety Agents; Brain Injuries; Buspirone; Humans; Male; Mental Disorders; Middle Aged | 1998 |
Clinical studies of "specific" anxiolytics as therapeutic agents.
Topics: Agoraphobia; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Humans; Mental Diso | 1987 |